The overall aim of the Drug Evaluation Core is to provide support for routine procedures, assays and analyses required by the investigators of the Program Project. Generally, existing methodology will be used. New methods, or modifications of established methods, will be developed with the Projects and Cores as needed. Methods to be used by the Core include, but are not limited to, the following: (i) measurement of drug lipophilicity, using computer estimates, HPLC retention times and oil:buffer partitioning methods; (ii) determination of drug levels in cells, tissues and biological fluids using absorbance, fluorescence and extraction/dissolution methods. These methods will be performed for cultured cells, animal models, and patients in clinical trials; (iii) determination of photosensitizer concentrations using noninvasive in situ reflectance spectroscopy and fluorimetry. These measurements will be performed in animal models and patients in clinical trials; (iv) measurement of tumor response to PDT, including maintenance of electronic maintenance of electronic-caliper tumor measurement and computerized data storage systems; (v) measurement of vascular response to PDT using a fluorescein exclusion assay and specially constructed, non-invasive in situ fluorometer; (vi) measurement of normal tissue toxicity to PDT using the well established murine foot response model; (vii) measurement of cellular responses to PDT using in vitro and in vivo/ex vivo (excision assay) models; (viii)detection of photosensitizers and metabolites in cells, tissues and fluids using analytical HPLC. (ix) measurement of albumin binding of photosensitizers using high- performance displacement chromatography; (x) determine tissue and cellular sites of photosensitizer localization using confocal fluorescence microscopy; (xi) preparation of specimens for histology, histology method development. The activities of the Drug Evaluation Core will be essential for maximizing the yield of useful information from the integrated Projects and Cores in this Program Project. Core personnel will perform, direct or supervise these routine procedures, resulting in increased consistency as well as economy of scale; this consolidation will also improve quality control and will make it more feasible to exchange data between Projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA055791-06
Application #
6269522
Study Section
Project Start
1998-04-01
Project End
1999-01-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Tracy, Erin C; Bowman, Mary-Jo; Pandey, Ravendra K et al. (2018) Cell-specific Retention and Action of Pheophorbide-based Photosensitizers in Human Lung Cancer Cells. Photochem Photobiol :
Shafirstein, Gal; Bellnier, David A; Oakley, Emily et al. (2018) Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer. Br J Cancer 119:1191-1199
Egan, Shawn M; Karasik, Ellen; Ellis, Leigh et al. (2017) miR-30e* is overexpressed in prostate cancer and promotes NF-?B-mediated proliferation and tumor growth. Oncotarget 8:67626-67638
Harris, Kassem; Oakley, Emily; Bellnier, David et al. (2017) Endobronchial ultrasound-guidance for interstitial photodynamic therapy of locally advanced lung cancer-a new interventional concept. J Thorac Dis 9:2613-2618
Hall, Brandon M; Balan, Vitaly; Gleiberman, Anatoli S et al. (2017) p16(Ink4a) and senescence-associated ?-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli. Aging (Albany NY) 9:1867-1884
Shafirstein, Gal; Bellnier, David; Oakley, Emily et al. (2017) Interstitial Photodynamic Therapy-A Focused Review. Cancers (Basel) 9:
Saenz, Courtney; Cheruku, Ravindra R; Ohulchanskyy, Tymish Y et al. (2017) Structural and Epimeric Isomers of HPPH [3-Devinyl 3-{1-(1-hexyloxy) ethyl}pyropheophorbide-a]: Effects on Uptake and Photodynamic Therapy of Cancer. ACS Chem Biol 12:933-946
Oakley, Emily; Bellnier, David A; Hutson, Alan et al. (2017) Surface markers for guiding cylindrical diffuser fiber insertion in interstitial photodynamic therapy of head and neck cancer. Lasers Surg Med 49:599-608
Mimikos, Christina; Shafirstein, Gal; Arshad, Hassan (2016) Current state and future of photodynamic therapy for the treatment of head and neck squamous cell carcinoma. World J Otorhinolaryngol Head Neck Surg 2:126-129
Patel, Nayan; Pera, Paula; Joshi, Penny et al. (2016) Highly Effective Dual-Function Near-Infrared (NIR) Photosensitizer for Fluorescence Imaging and Photodynamic Therapy (PDT) of Cancer. J Med Chem 59:9774-9787

Showing the most recent 10 out of 167 publications